REFERENCES

• SaundersAM.StrittmatterWJ.SchmechelD.et alAssociation of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.Neurology.199343146714728350998
   PubMed Web of Science ®Google Scholar
• StrittmatterWJ.SaundersAM.SchmechelD.et alApolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proc Natl Acad Sci USA.199390197719818446617
   PubMed Web of Science ®Google Scholar
• RebeckGW.ReiterJS.StricklandDK.HymanBT.Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.Neuron.1993115755808398148
   PubMed Web of Science ®Google Scholar
• CaselliRJ.ReimanEM.LockeDE.et alCognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.Arch Neurol.2007641306131117846270
   PubMedGoogle Scholar
• luresciaS.FiorettiD.MangialascheF.RinaldiM.The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.J Alzheimers Dis.201021354820182014
   PubMed Web of Science ®Google Scholar
• PfriegerFW.Role of cholesterol in synapse formation and function.Biochem Biophys Acta.2003161027128012648780
   PubMed Web of Science ®Google Scholar
• HanX.The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease.Mol Neurobiol.2010419710620052565
   PubMed Web of Science ®Google Scholar
• YasunoF.TanimukaiS.SasakiM.et alAssociation between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype.Am J Geriatr Psychiatry.20112057458321407046
   PubMed Web of Science ®Google Scholar
• YasunoF.TanimukaiS.SasakiM.et alEffect of plasma lipids, hypertension and APOE genotype on cognitive decline.Neurobiol Aging.2012332633264022285757
   PubMed Web of Science ®Google Scholar
• MiyamotoM.KodamaC.KinoshitaT.et alDementia and mild cognitive impairment among non-responders to a community survey.J Clin Neurosci.20091627027619091575
   PubMed Web of Science ®Google Scholar
• SohlbergM.MateerCA. Attention Process Training Manual. Washington, DC: Association for Neuropsychological Research & Development; 1986
   Google Scholar
• GroberE.BuschkeH.CrystalH.BangS.DresnerR.Screening for dementia by memory testing.Neurology.1988389009033368071
   PubMed Web of Science ®Google Scholar
• SolomonPR.PendleburyWW.Recognition of Alzheimer's disease: the 7 Minute Screen.Fam Med.1998302652719568495
   PubMedGoogle Scholar
• WechslerD. WAIS-R: Manual: Wechsler Adult Intelligence Scale-Revised. New York, NY: Harcourt Brace Jovanovich for Psychological Corp; 1981
   Google Scholar
• SmallBJ.RosnickCB.FratiglioniL.BäckmanL.Apolipoprotein E and cognitive performance: a meta-analysis.Psychol Aging.20041959260015584785
   PubMed Web of Science ®Google Scholar
• DavignonJ.CohnJS.MabileL.BernierL.Apolipoprotein E and atherosclerosis: insight from animal and human studies.Clin Chim Acta.199928611514310511288
   PubMed Web of Science ®Google Scholar
• TangiralaRK.PraticóD.FitzGeraldGA.et alReduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.J Biol Chem.200127626126611024044
   PubMed Web of Science ®Google Scholar
• MasliahE.MalloryM.GeN.AlfordM.VeinbergsI.RosesAD.Neurodegeneration in the central nervous system of apoE-deficient mice.Exp Neurol.19951361071227498401
   PubMed Web of Science ®Google Scholar
• StratmanNC.CastleCK.TaylorBM.EppsDE.MelchiorGW.CarterDB.Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.Chem Phys Lipids.2005137526116140289
   PubMed Web of Science ®Google Scholar
• ChawlaA.BoisvertWA.LeeCH.et alA PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.Mol Cell.2001716117111172721
   PubMed Web of Science ®Google Scholar
• CramerPE.CirritoJR.WessonDW.et alApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.Science.20123351503150622323736
   PubMed Web of Science ®Google Scholar
• StrittmatterWJ.Medicine. Old drug, new hope for Alzheimer's disease.Science.20123351447144822442467
   PubMed Web of Science ®Google Scholar
• BretelerMM.van SwietenJC.BotsML.et alCerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.Neurology.199444124612528035924
   PubMed Web of Science ®Google Scholar
• KalariaRN.The role of cerebral ischemia in Alzheimer's disease.Neurobiol Aging20002132133010867217
   PubMed Web of Science ®Google Scholar
• KoudinovAR.BerezovTT.KumarA.KoudinovaNV.Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids.Clin Chim Acta.199827075849544446
   PubMed Web of Science ®Google Scholar
• OlesenOF.DagøL.High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils.Biochem Biophys Res Commun.2000270626610733905
   PubMed Web of Science ®Google Scholar
• CockerillGW.HuehnsTY.WeerasingheA.et alElevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation.Circulation.200110310811211136694
   PubMed Web of Science ®Google Scholar
• HeerenJ.GrewalT.LaatschA.et alRecycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization.J Biol Chem.2003278143701437812584196
   PubMed Web of Science ®Google Scholar
• HeerenJ.GrewalT.LaatschA.et alImpaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation.J Biol Chem.2004279554835549215485881
   PubMed Web of Science ®Google Scholar